Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-04-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Group
The intervention is a structured walking program which will be performed partly in the Pavilion Physical Therapy clinic and partly at home. The participant will be instructed in how hard to exercise, how long to exercise, and how many times in a week to exercise. You will also be instructed in how to exercise safely.
Exercise
The participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks.
No Exercise
These participants will receive standard of care follow up.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
The participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female
* BMI \> 25
* Weight \< 350 pounds
* English as a primary language
* Postmenopausal
* Invasive ER-positive cancer on biopsy and subsequent definitive surgical therapy
* Received and Completed standard of care adjuvant therapy (Concurrent endocrine therapy acceptable)
* 6-12 months after completion of therapy (excluding adjuvant endocrine therapy) at time of randomization
Exclusion Criteria
* DCIS only (no invasive component)
* Taking a Beta Blocker or Verapamil
* Pregnant
* Wheelchair bound
* Unable to ambulate independently
* Concurrent uncontrolled medical or psychiatric disorder
* Open wound
* Stage IV breast cancer
* Progression of disease
* Bilateral mastectomies
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Mississippi Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Natale Sheehan
Assistant Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natale Sheehan, MD
Role: PRINCIPAL_INVESTIGATOR
University of Mississippi Health Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Mississippi Health Care
Jackson, Mississippi, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-0121
Identifier Type: -
Identifier Source: org_study_id